This study showed that NFE2L3 expression was also significantly positively correlated with three immunomodulators, including immunoinhibitory, immunostimulatory, and MHC molecules in TCGA pan-cancer cohort (Supplementary Figure S2). Here, NFE2L3 is linked to cancer.